Amwell to Participate in Upcoming Investor Conferences
Amwell (NYSE: AMWL), a leader in telehealth, announced participation in key investor conferences. On May 11, 2022, Dr. Ido Schoenberg, CEO, and CFO Bob Shepardson will present at the BofA Healthcare Conference in Las Vegas. They will also participate in the RBC Capital Markets Healthcare Conference in New York City on May 17, 2022, at 2:05 p.m. ET, and at the Needham Virtual Tech and Media Conference on May 19, 2022, at 10:15 a.m. ET. Audio webcasts will be available on their investor relations website.
- None.
- None.
-
At the
BofA 2022Securities Healthcare Conference inLas Vegas, Nev. onMay 11, 2022 , Dr.Ido Schoenberg , Chairman and CEO andBob Shepardson , CFO will present in person during a fireside chat at4:00 p.m. PT and conduct one-on-one meetings with investors. -
On
May 17, 2022 ,Dr. Schoenberg andMr. Shepardson will also present in person during a fireside chat at theRBC Capital Markets Healthcare Conference inNew York City and conduct one-on-one meetings with investors. The fireside chat will be at2:05 p.m. ET . -
Dr. Schoenberg andMr. Shepardson will also participate in a fireside chat and conduct one-on-one meetings at theNeedham Virtual Tech and Media Conference onMay 19, 2022 . The fireside chat will be at10:15 a.m. ET .
Audio webcasts will be available online at https://investors.amwell.com.
About Amwell
Amwell is a leading telehealth platform in
Forward-Looking Statements
This press release contains forward-looking statements about us and our industry that involve substantial risks and uncertainties and are based on our beliefs and assumptions and on information currently available to us. All statements other than statements of historical facts contained in this press release, including statements regarding our future results of operations, financial condition, business strategy and plans and objectives of management for future operations, are forward-looking statements. In some cases, you can identify forward-looking statements because they contain words such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “will,” or “would,” or the negative of these words or other similar terms or expressions.
Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Forward-looking statements represent our beliefs and assumptions only as of the date of this release. These statements, and related risks, uncertainties, factors and assumptions, include, but are not limited to: weak growth and increased volatility in the telehealth market; inability to adapt to rapid technological changes; increased competition from existing and potential new participants in the healthcare industry; changes in healthcare laws, regulations or trends and our ability to operate in the heavily regulated healthcare industry; our ability to comply with federal and state privacy regulations; the significant liability that could result from a cybersecurity breach; and other factors described under ‘Risk Factors’ in our most recent form 10-K filed with the
View source version on businesswire.com: https://www.businesswire.com/news/home/20220425005970/en/
Media:
press@amwell.com
Investors:
sue.dooley@amwell.com
415-602-9167
Source: Amwell
FAQ
What key investor conferences is Amwell participating in during May 2022?
Who will present at the BofA Healthcare Conference for Amwell?
What time will Amwell's presentation be at the RBC Capital Markets Healthcare Conference?
Where can I listen to the webcasts for Amwell's investor presentations?